AAAAAA
Results:
1-13
|
Results: 13
Authors:
Chiesa, R
Pestronk, A
Schmidt, RE
Tourtellotte, VG
Ghetti, B
Piccardo, P
Harris, DA
Citation: R. Chiesa et al., Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation, NEUROBIOL D, 8(2), 2001, pp. 279-288
Authors:
Connolly, AM
Keeling, RM
Mehta, S
Pestronk, A
Sanes, JR
Citation: Am. Connolly et al., Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha 2-deficient mice, NEUROMUSC D, 11(8), 2001, pp. 703-712
Authors:
Fenichel, GM
Griggs, RC
Kissel, J
Kramer, TI
Mendell, JR
Moxley, RT
Pestronk, A
Sheng, K
Florence, J
King, WM
Pandya, S
Robison, VD
Wang, H
Citation: Gm. Fenichel et al., A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy, NEUROLOGY, 56(8), 2001, pp. 1075-1079
Authors:
Lopate, G
Kornberg, AJ
Yue, J
Choksi, R
Pestronk, A
Citation: G. Lopate et al., Anti-myelin associated glycoprotein antibodies: variability in patterns ofIgM binding to peripheral nerve, J NEUR SCI, 188(1-2), 2001, pp. 67-72
Authors:
Pestronk, A
Citation: A. Pestronk, Testing for serum IgM binding to GM1 ganglioside in clinical practice, NEUROLOGY, 54(12), 2000, pp. 2353-2353
Authors:
Mozaffar, T
Pestronk, A
Citation: T. Mozaffar et A. Pestronk, Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres, J NE NE PSY, 68(4), 2000, pp. 472-478
Authors:
Nevo, Y
Al-Lozi, M
Parsadanian, AS
Elliott, JL
Connolly, AM
Pestronk, A
Citation: Y. Nevo et al., Mutation analysis in Emery-Dreifuss muscular dystrophy, PED NEUROL, 21(1), 1999, pp. 456-459
Authors:
Levine, TD
Pestronk, A
Citation: Td. Levine et A. Pestronk, IgM antibody-related polyneuropathies: B-cell depletion chemotherapy usingRituximab, NEUROLOGY, 52(8), 1999, pp. 1701-1704
Authors:
Kasarskis, EJ
Shefner, JM
Miller, R
Smith, RA
Licht, J
Mitsumoto, H
Hopkins, LC
Rosenfeld, J
Pascuzzi, R
Cornblath, DR
Armon, C
Strong, MJ
Kula, R
Windebank, A
Bosch, EP
Smith, BE
Cashman, N
Sivak, M
Sergay, S
Siddique, T
Sufit, RL
Johnston, W
Brooke, MB
Graves, MC
Olney, RK
Roos, RP
Neville, H
Ringel, SP
Ross, M
Bradley, WG
Sharma, KR
Parry, G
Mandler, R
Giuliani, M
Thornton, CA
Jackson, C
Bryan, W
Bromberg, M
Tandan, R
Fries, T
Phillips, L
Brooks, BR
Fenichel, G
Pestronk, A
Bear, M
Beatey, R
Fuller, C
Hill, R
Malta, E
Nakanishi, A
Patel, A
Thurmond, B
Cedarbaum, JM
Stambler, N
Citation: Ej. Kasarskis et al., A controlled trial of recombinant methionyl human BDNF in ALS, NEUROLOGY, 52(7), 1999, pp. 1427-1433
Authors:
Connolly, AM
Chez, MG
Pestronk, A
Arnold, ST
Mehta, S
Deuel, RK
Citation: Am. Connolly et al., Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders, J PEDIAT, 134(5), 1999, pp. 607-613
Authors:
Calhoun, RF
Ritter, JH
Guthrie, TJ
Pestronk, A
Meyers, BF
Patterson, GA
Pohl, MS
Cooper, JD
Citation: Rf. Calhoun et al., Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients, ANN SURG, 230(4), 1999, pp. 555-559
Authors:
Pestronk, A
Choksi, R
Yee, WC
Kornberg, AJ
Lopate, G
Trotter, J
Citation: A. Pestronk et al., Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barre syndrome and other demyelinating polyneuropathies, J NEUROIMM, 91(1-2), 1998, pp. 204-209
Authors:
Pestronk, A
Citation: A. Pestronk, Multifocal motor neuropathy: Diagnosis and treatment, NEUROLOGY, 51(6), 1998, pp. S22-S24
Risultati:
1-13
|